CLINICAL_TRIALS
trial_result
· 2014-05-12
Clinical Trial Update: Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy [Phase 2]
Summary
Phase 2 study updating the effect of Zometa on bone mineral density in prostate cancer patients undergoing androgen deprivation therapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-05-12